Pathogenesis of chagas' disease: parasite persistence and autoimmunity

ARL Teixeira, MM Hecht, MC Guimaro… - Clinical microbiology …, 2011 - Am Soc Microbiol
Acute Trypanosoma cruzi infections can be asymptomatic, but chronically infected
individuals can die of Chagas' disease. The transfer of the parasite mitochondrial kinetoplast …

Computational biology in the study of cardiac ion channels and cell electrophysiology

Y Rudy, JR Silva - Quarterly reviews of biophysics, 2006 - cambridge.org
1. Prologue 582. The Hodgkin–Huxley formalism for computing the action potential 592.1
The axon action potential model 592.2 Cardiac action potential models 623. Ion-channel …

Innovative approaches to anti-arrhythmic drug therapy

S Nattel, L Carlsson - Nature reviews Drug discovery, 2006 - nature.com
Normal cardiac function requires an appropriate and regular beating rate (cardiac rhythm).
When the heart rhythm is too fast or too slow, cardiac function can be impaired, with …

Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy

PJ Kannankeril, BM Mitchell… - Proceedings of the …, 2006 - National Acad Sciences
Mutations in the cardiac ryanodine receptor 2 (RyR2) have been associated with
catecholaminergic polymorphic ventricular tachycardia and a form of arrhythmogenic right …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - Elsevier
BACKGROUND: The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …

Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing

DJ Tester, P Arya, M Will, CM Haglund, AL Farley… - Heart Rhythm, 2006 - Elsevier
BACKGROUND: Mutations in the RyR2-encoded cardiac ryanodine receptor/calcium
release channel and in CASQ2-encoded calsequestrin cause catecholaminergic …

[HTML][HTML] Graded maximal exercise testing to assess mouse cardio-metabolic phenotypes

JM Petrosino, VJ Heiss, SK Maurya… - Plos one, 2016 - journals.plos.org
Functional assessments of cardiovascular fitness (CVF) are needed to establish animal
models of dysfunction, test the effects of novel therapeutics, and establish the cardio …

Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation

S Pizzale, MH Gollob, R Gow… - Journal of cardiovascular …, 2008 - Wiley Online Library
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial condition that
presents with exercise‐induced syncope or sudden death in children or young adults. In …

Sudden cardiac death: epidemiology, mechanisms, and therapy

M Turakhia, ZH Tseng - Current problems in cardiology, 2007 - Elsevier
Sudden cardiac death is a major public health problem affecting 500,000 patients annually
in the United States alone. The major risk factor for sudden cardiac death is the presence of …

In the RyR2R4496C Mouse Model of CPVT, β-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca …

T Kashimura, SJ Briston, AW Trafford… - Circulation …, 2010 - Am Heart Assoc
Rationale: Mutations of the ryanodine receptor (RyR) cause catecholaminergic polymorphic
ventricular tachycardia (CPVT). These mutations predispose to the generation of Ca waves …